// App-Quantinova.ai

1414 : Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly‐sensitization BALB/c model

Researchers

Presenter

  • Afify SM

Principal Investigators

  • Pali-Schll I

  • Regner A

  • Petje LM

  • Hufnagl K

  • guethoff S

  • Roth-Walter F

  • Jensen-Jarolim E

Medical Centers

  • The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria

  • Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectology and Immunology, Medical University Vienna, Vi- enna, Austria

  • Laboratory Medicine and Immunology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt

  • Bencard Allergie Gmbh, Munich, Germany

  • Allergy Therapeutics Ltd, Worthing, United Kingdom

  • Biomedical International R+D GmbH, Vienna, Austria

Locations

  • Austria

  • Egypt

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved